Capricor Therapeutics (CAPR) Other Non-Current Assets (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Other Non-Current Assets of $1.5 million for Q1 2026, up 505.27% year-over-year from $253374.0 in Q1 2025, and up 32.27% quarter-over-quarter from $1.2 million in Q4 2025.
Capricor Therapeutics (CAPR) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 505.27% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (up 505.27% YoY), while the FY2025 annual figure was $1.2 million, up 423.0% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $1.5 million, up from $1.2 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $1.5 million in Q1 2026, with the low at $221700.0 in Q4 2024.
- The 5-year median for Other Non-Current Assets is $268172.0 (2022), against an average of $426490.4.
- The sharpest annual moves came in 2024 and 2026: Other Non-Current Assets slipped 17.33% in 2024, then surged 505.27% in 2026.
- Capricor Therapeutics' Other Non-Current Assets stood at $268172.0 in 2022, then changed by 0.0% to $268172.0 in 2023, then decreased by 17.33% to $221700.0 in 2024, then soared by 423.0% to $1.2 million in 2025, then surged by 32.27% to $1.5 million in 2026.
- Business Quant data shows CAPR's Other Non-Current Assets at $1.5 million in Q1 2026, $1.2 million in Q4 2025, and $488738.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | 1.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 488,738.00 |
| Jun 30, 2025 | 508,002.00 |
| Mar 31, 2025 | 253,374.00 |
| Dec 31, 2024 | 221,700.00 |
| Sep 30, 2024 | 319,246.00 |
| Jun 30, 2024 | 319,558.00 |
| Mar 31, 2024 | 293,722.00 |
| Dec 31, 2023 | 268,172.00 |
| Sep 30, 2023 | 268,172.00 |
| Jun 30, 2023 | 268,172.00 |
| Mar 31, 2023 | 268,172.00 |
| Dec 31, 2022 | 268,172.00 |
| Sep 30, 2022 | 268,172.00 |
| Jun 30, 2022 | 268,172.00 |
| Mar 31, 2022 | 275,722.00 |
| Dec 31, 2021 | 275,722.00 |
| Sep 30, 2021 | 288,701.00 |
| Jun 30, 2021 | 88,701.00 |